Literature DB >> 9425533

Cytochrome oxidase in Alzheimer's disease: biochemical, histochemical, and immunohistochemical analyses of the visual and other systems.

M Wong-Riley1, P Antuono, K C Ho, R Egan, R Hevner, W Liebl, Z Huang, R Rachel, J Jones.   

Abstract

Defects in oxidative metabolism have been implicated in Alzheimer's disease (AD). The present study evaluated the level of cytochrome oxidase (C.O.), an indicator of neuronal oxidative capacity, in various brain regions of post-mortem AD and control patients. We found a statistically significant reduction in C.O. levels in all cortical areas examined, including the primary and secondary visual cortices. In addition, all layers of the dorsal lateral geniculate nucleus and sublaminae of the primary visual cortex in AD cases examined suffered a reduction in their relative C.O. activity and protein amount. Our results suggest a generalized suppression of oxidative metabolism throughout the cortex, as well as in a major subcortical visual center in AD. Such hypometabolism may form the basis for not only deficits in higher cortical functions, but also a variety of visual dysfunctions known to occur in AD.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9425533     DOI: 10.1016/S0042-6989(96)00210-6

Source DB:  PubMed          Journal:  Vision Res        ISSN: 0042-6989            Impact factor:   1.886


  29 in total

1.  The expression of several mitochondrial and nuclear genes encoding the subunits of electron transport chain enzyme complexes, cytochrome c oxidase, and NADH dehydrogenase, in different brain regions in Alzheimer's disease.

Authors:  M Y Aksenov; H M Tucker; P Nair; M V Aksenova; D A Butterfield; S Estus; W R Markesbery
Journal:  Neurochem Res       Date:  1999-06       Impact factor: 3.996

Review 2.  Role of mitochondrial homeostasis and dynamics in Alzheimer's disease.

Authors:  J Eva Selfridge; Lezi E; Jianghua Lu; Russell H Swerdlow
Journal:  Neurobiol Dis       Date:  2012-01-10       Impact factor: 5.996

3.  Development of (17)O NMR approach for fast imaging of cerebral metabolic rate of oxygen in rat brain at high field.

Authors:  Xiao-Hong Zhu; Yi Zhang; Run-Xia Tian; Hao Lei; Nanyin Zhang; Xiaoliang Zhang; Hellmut Merkle; Kamil Ugurbil; Wei Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-19       Impact factor: 11.205

Review 4.  Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease.

Authors:  L Holper; D Ben-Shachar; J J Mann
Journal:  Neuropsychopharmacology       Date:  2018-05-16       Impact factor: 7.853

5.  Visual deficits in a mouse model of Batten disease are the result of optic nerve degeneration and loss of dorsal lateral geniculate thalamic neurons.

Authors:  Jill M Weimer; Andrew W Custer; Jared W Benedict; Noreen A Alexander; Evan Kingsley; Howard J Federoff; Jonathan D Cooper; David A Pearce
Journal:  Neurobiol Dis       Date:  2006-01-18       Impact factor: 5.996

Review 6.  Amyloid precursor protein-mediated mitochondrial regulation and Alzheimer's disease.

Authors:  M Isabel G Lopez Sanchez; Peter van Wijngaarden; Ian A Trounce
Journal:  Br J Pharmacol       Date:  2018-12-18       Impact factor: 8.739

7.  Mitochondrial abnormalities in Alzheimer's disease.

Authors:  K Hirai; G Aliev; A Nunomura; H Fujioka; R L Russell; C S Atwood; A B Johnson; Y Kress; H V Vinters; M Tabaton; S Shimohama; A D Cash; S L Siedlak; P L Harris; P K Jones; R B Petersen; G Perry; M A Smith
Journal:  J Neurosci       Date:  2001-05-01       Impact factor: 6.167

Review 8.  Imaging Guidance for Therapeutic Delivery: The Dawn of Neuroenergetics.

Authors:  Vilakshan Alambyan; Jonathan Pace; Persen Sukpornchairak; Xin Yu; Hamza Alnimir; Ryan Tatton; Gautham Chitturu; Anisha Yarlagadda; Ciro Ramos-Estebanez
Journal:  Neurotherapeutics       Date:  2020-04       Impact factor: 7.620

9.  Different proteolipid protein mutants exhibit unique metabolic defects.

Authors:  Maik Hüttemann; Zhan Zhang; Chadwick Mullins; Denise Bessert; Icksoo Lee; Klaus-Armin Nave; Sunita Appikatla; Robert P Skoff
Journal:  ASN Neuro       Date:  2009-08-25       Impact factor: 4.146

10.  Evidence for ape and human specializations in geniculostriate projections from VGLUT2 immunohistochemistry.

Authors:  Katherine L Bryant; Carolyn Suwyn; Katherine M Reding; John F Smiley; Troy A Hackett; Todd M Preuss
Journal:  Brain Behav Evol       Date:  2012-08-10       Impact factor: 1.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.